Black and Hispanic Patients are More Likely to be Treated with Disease Modifying Therapies for Multiple Sclerosis than White patients: Medicare Analysis 2014-2016

被引：0
|
作者：
Xu, L. [1 ]
Williams, M. [2 ]
Amezcua, L. [3 ]
Vignos, M. [4 ]
Gamba, J. [4 ]
Puckrein, G. [1 ]
机构：
[1] Natl Minor Qual Forum, Washington, DC USA
[2] Multiple Sclerosis Ctr Atlanta, Atlanta, GA USA
[3] Keck Sch Med, Dept Neurol, Los Angeles, CA USA
[4] Biogen, Cambridge, MA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2022年 / 28卷 / 1_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P326
引用
收藏
页码：169 / 169
页数：1
相关论文
共 50 条
  • [41] Prevalence of Treatment Interruptions for Disease Modifying Therapies among Patients with Multiple Sclerosis
    Lublin, F. D.
    Rossi, C.
    Le, H. H.
    Holiday, C.
    Lefebvre, P.
    Pilon, D.
    Keenan, A.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 201 - 202
  • [42] Disease Modifying Therapies Modulate Cardiovascular Risk Factors in Patients with Multiple Sclerosis
    Sternberg, Zohara
    Leung, Christopher
    Sternberg, Daniel
    Yu, Jinhee
    Hojnacki, David
    CARDIOVASCULAR THERAPEUTICS, 2014, 32 (02) : 33 - 39
  • [43] Identification of a gene expression signature in peripheral blood of multiple sclerosis patients treated with disease-modifying therapies
    Cordiglieri, Chiara
    Baggi, Fulvio
    Bernasconi, Pia
    Kapetis, Dimos
    Faggiani, Elisa
    Consonni, Alessandra
    Andreetta, Francesca
    Frangiamore, Rita
    Confalonieri, Paolo
    Antozzi, Carlo
    Mantegazza, Renato
    CLINICAL IMMUNOLOGY, 2016, 173 : 133 - 146
  • [44] Cancer risk for multiple sclerosis patients treated with azathioprine and disease-modifying therapies: an Italian observational study
    Loredana La Mantia
    Maria Donata Benedetti
    Milena Sant
    Alessia d’Arma
    Sonia Di Tella
    Roberto Lillini
    Laura Mendozzi
    Antonio Marangi
    Marco Turatti
    Domenico Caputo
    Marco Rovaris
    Neurological Sciences, 2021, 42 : 5157 - 5163
  • [45] Immune response to COVID-19 vaccines in patients with multiple sclerosis treated with disease-modifying therapies
    Brola, Waldemar
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2023, 57 (01) : 11 - 13
  • [46] Effect of SARS-CoV-2 mRNA vaccination in multiple sclerosis patients treated with disease modifying therapies
    Sormani, M. P.
    Inglese, M.
    Schiavetti, I.
    Carmisciano, L.
    Laroni, A.
    Lapucci, C.
    Da Rin, G.
    Serrati, C.
    Gandoglia, I.
    Tassinari, T.
    Perego, G.
    Brichetto, G.
    Gazzola, P.
    Mannironi, A.
    Stromillo, M. L.
    Cordioli, C.
    Landi, D.
    Clerico, M.
    Signoriello, E.
    Frau, J.
    Ferro, M. T.
    Di Sapio, A.
    Pasquali, L.
    Ulivelli, M.
    Marinelli, F.
    Callari, G.
    Iodice, R.
    Liberatore, G.
    Caleri, F.
    Repice, A. M.
    Cordera, S.
    Battaglia, M. A.
    Salvetti, M.
    Franciotta, D.
    Uccelli, A.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 743 - 744
  • [47] Changes in John Cunningham Virus Index in Multiple Sclerosis Patients Treated with Different Disease-Modifying Therapies
    Sgarlata, Eleonora
    Chisari, Clara Grazia
    Toscano, Simona
    Finocchiaro, Chiara
    Lo Fermo, Salvatore
    Millefiorini, Enrico
    Patti, Francesco
    CURRENT NEUROPHARMACOLOGY, 2022, 20 (10) : 1978 - 1987
  • [48] Three doses of COVID-19 vaccines in multiple sclerosis patients treated with disease-modifying therapies
    Baba, Cavid
    Ozcelik, Sinem
    Kaya, Ergi
    Samedzada, Ulvi
    Ozdogar, Asiye Tuba
    Cevik, Sumeyye
    Dogan, Yavuz
    Ozakbas, Serkan
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 68
  • [49] Herpes Zoster Virus (HZV) Infections among Multiple Sclerosis Patients Treated with Various Disease Modifying Therapies
    Carlisle, Nicola
    Hooshmand, Sam I.
    Maynard, Michelle
    Hoffman, Leah
    Obeidat, Ahmed
    NEUROLOGY, 2020, 94 (15)
  • [50] Cancer risk for multiple sclerosis patients treated with azathioprine and disease-modifying therapies: an Italian observational study
    La Mantia, Loredana
    Benedetti, Maria Donata
    Sant, Milena
    d'Arma, Alessia
    Di Tella, Sonia
    Lillini, Roberto
    Mendozzi, Laura
    Marangi, Antonio
    Turatti, Marco
    Caputo, Domenico
    Rovaris, Marco
    NEUROLOGICAL SCIENCES, 2021, 42 (12) : 5157 - 5163
12345